The FDA has cleared GSK's PD-1 inhibitor Jemperli as a treatment for all adult patients with primary advanced or recurrent endometrial cancer, a key part of the company's growth ambitions for the ...
GSK’s Jemperli has claimed an edge over its main rival in the endometrial cancer therapy market after showing improved overall survival in a broad patient population in the RUBY trial.
H.C. Wainwright updated AnaptysBio’s model to include $75M in milestones from GSK to the company in 2026 for $1B in annual sales of Jemperli. In addition, it increased estimates for ...
Also, treatment with Jemperli plus chemotherapy demonstrated a median OS of 44.6 months compared with 28.2 months for chemotherapy alone. Jemperli was approved for similar expanded use in ...
The European Commission (EC) has approved GSK's Jemperli (dostarlimab) combined with chemotherapy that includes carboplatin and paclitaxel for the first-line treatment of primary advanced or ...
From the March/April 2025 issue of Car and Driver. You'd think the sight of a new MG might attract more attention, whether it was spied carving up the winding roads of rural Scotland or whizzing ...
A long-standing practice of Autocar India’s long-term fleet has been turned on its head by the MG Comet. For years, we’d run our respective long-termers (usually small cars) on the daily ...
The recommended dosage for ashwagandha can vary depending on your needs, but most research suggests that taking 250–500 milligrams (mg) per day for at least one month may be beneficial ...
The Jemperli Dostarlimab market size has brought about notable growth and shifts in recent years. With a history of significant compound annual growth rate HCAGR, the ...
Is the MG4 a good car? Small electric cars have historically been expensive, but the MG4 marked the beginning of price parity with more traditionally powered hatchbacks. But it isn't just the ...
Here’s how much the super-rich are really worth Mark Cussen, CMFC, has 13+ years of experience as a writer and provides financial education to military service members and the public. Mark is an ...